|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9 |
YES |
Agonist monoclonal (anti-CD137) in clinical trials [35]
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I member 1 |
YES |
Related serine protease family inhibitors used clinically (aprotinin, A1AT) |
|
RARRES1
|
retinoic acid receptor responder |
YES |
Up-regulated by tazarotene [36], FDA-approved drug |
|
CLNS1A
|
chloride channel, nucleotide- sensitive, 1A |
YES |
Multiple chloride channel enhancing drugs for CF [37]
|
|
TRIM10
|
tripartite motif-containing 10 |
YES |
Zinc/metal binding domain suggests chelator function; chelators picolinic acid, desferal in clinical use |
